Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines

Hospital Pharmacy

Volumn 31, Issue 10, 1996, Pages 1283-1289

  Murphy, John E ^a   Carter, Jean T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

aminoglycosides; drug concentration measurement; gentamicin

Indexed keywords

GENTAMICIN;

BIRTH WEIGHT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MONITORING; PHARMACIST; REVIEW; STEADY STATE;

EID: 0029970721     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Mulhall A, De Louvois J, Hurley R Incidence of potentially toxic concentrations of gentamicin in the neonate. Arch Dis Child. 1983;58:897-900.
2. Szefler SJ, Wynn RJ, Clarke DF, Buckwald SB, Shen D, Schentag JJ. Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates. J Pediatr. 1980;97:312-315.
3. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987;155:93-99.
4. Barza M, Lauermann M. Why monitor serum concentrations of gentamicin? Clin Pbarmacokinet. 1978;3:202-215.
5. Benitz WE, Tatro DS. The Pediatric Drug Handbook. 2nd ed Yearbook Medical Publications, Inc; 1988, 505-506.
6. Taketomo C, Hodding J, Kraus D. Pediatric Dosage Handbook. Lexicomp; 1992, 213-215.
7. The Harriet Lane Handbook. 11th ed. Mosby Yearbook; 1987:162.
8. Young TE, Mangum OB. Neofax. 4th ed. Ross Lab; 1991, 28-29.
9. McCracken GH. Aminoglycoside toxicity in infants and children. Am J Med. 1986;80(Supp6b) 172-178.
10. Kasik JW, Jenkins S, Leuschen MP, Nelson RM Postconceptual age and gentamicin elimination half-life. J Pediatr. 1985;106: 502-505.
11. Miranda JC, Schimmel MM, James LS, Spinelli W, Rosen TS. Gentamicin kinetics in the neonate. Pediatr Pharmacol. 1985,5: 57-61.
12. Izquierdo M, Lanao JM, Cervero L, Jimenez NV, Dominguez-gil A. Population pharmacokinetics of gentamicin in premature infants. Ther Drug Monit. 1992, 14(3):177-183.
13. deCos MA, Gomez-Ullate J, Gomez F, Armijo JA. Time course of trough serum gentamicin concentrations in preterm and term neonates. Clin Pharmacokinet. 1992, 23(5). 391-401.
14. Edwards C, Low DC, Bissenden JG. Gentamicin dosage for the newborn. Lancet. 1986;1:508-509.
15. Assael BM, Gianni V, Marini A, Peneff P, Sereni F. Gentamicin dosage in preterm and term neonates. Arch Dis Child. 1977. 52:883-886.
16. Hindmarsh KW, Nation RL, Williams GL, John E, French JN. Pharmacokinetics of gentamicin in very Low birth weight preterm infants. Eur J Clin Pharmacol 1983;24: 649-653.
17. Thomson AH, Way S, Bryson SM, McGovern EM, Kelman AW. Population pharmacokinetics of gentamicin in neonates. Drug Intell Clin Pharm. 1988;11:173-179.
18. Bloome MR, Warren AJ, Ringer L, Walker PC. Evaluation of an empirical dosing schedule for gentamicin in neonates. Drug Intell Clin Pharm. 1988;22:618-622.
19. Faura CC, Feret MA, Horga JF. Monitoring serum concentrations of gentamicin to develop a new regimen for gentamicin dosage in newborns Ther Drug Monit. 1991;13:268-276.
20. Lopez-Samblas AM, Torres CL, Wang H, Feuer WJ, Goldberg RN. Effectiveness of a gentamicin dosing protocol based on post-conceptional age: Comparison to published neonatal guidelines. Ann Pharmacother. 1992;26:534-537.
21. Gennrich JL, Nitake M. Devising an aminoglycoside dosage regimen for neonates seven to ninety days chronological age. Neo Pharm Quarterly. 1992; 11(2):45-50
22. Pons G, d'Athis ER, DeLauture D, Richard MO, Badoual RJ, Olive G, Gentamicin monitoring in neonates. Ther Drug Monit. 1988;10:421-427
23. Faura CC, Garcia MR, Horga JE Changes in gentamicin serum concentrations and pharmacokinetic parameters in the newborn in the course of treatment with aminoglycoside. Ther Drug Monit. 1991;13.277-280.
24. Semchuk W, Borgmann J, Bowman L. Determination of a gentamicin loading dose in neonates and infants. Ther Drug Monit. 1993;15(1):47-51.
25. Charlton CK, Needelman H, Thomas RW, Kortas K. Gentamicin dosage recommendations for neonates based on half-life predictions from birthweight. Am J Perinatol. 1986;3(1):28-32.
26. Keyes PS, Johnson CK, Rawlins TD. Predictors of trough serum gentamicin concentrations in neonates. AJDC. 1989,143: 1419-1423.
27. Leff RD Anderson RD, Roberts RJ. Simplified gentamicin dosing in neonates: A time and cost-efficient approach Pediat Infect Dis. 1984;3:208-212.
28. Feldman H Guignard JP Plasma creatinine in the first month of life. Arch Dis Child. 1982;57:123-126
29. Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients. J Pharmacokinetics and Biopharmaceutics 1976;4:183-195.
30. Kirkwood BR. Essentials of Medical Statistics. Blackwell Scientific Publications, 1988, 57-63.
31. Walson PD, Edwards R, Cox S. Neonatal therapeutic drug monitoring - its clinical relevance. Ther Drug Monit. 1989;11: 425-430.
32. Murphy JE, Slack MK. National Survey of Hospital-Based Pharmacokinetic Services. Proceedings of the 30th Annual ASHP Midyear Clinical Meeting, Las Vegas, NV, December 6, 1995.